GLP-1s and fertility: the 'Ozempic baby' surprise, and the contraception catch no one mentions

The 30-second summary

• Some women are getting pregnant unexpectedly on GLP-1s, the so-called "Ozempic babies." It is not a coincidence: weight loss can restore ovulation, especially in women with PCOS or irregular cycles.
• There is a second, less-discussed reason: these drugs can reduce how well the pill is absorbed, so a woman relying on oral contraception may be less protected than she thinks.
• These drugs are not safe in pregnancy and should be stopped well before trying to conceive. If you do not want to be pregnant, this is the moment to check your contraception is one the drug cannot undermine.

Why fertility comes back

For many women, weight and fertility are linked through hormones. Excess body fat and insulin resistance can disrupt ovulation, which is one reason so many women with PCOS struggle to conceive and have irregular or absent periods.

GLP-1 drugs change that equation. As weight comes down and insulin sensitivity improves, the hormonal signals that drive ovulation can switch back on. Periods that were irregular for years can become regular. Ovulation that was not happening can resume. For a woman who had quietly given up on conceiving, that can happen before she realises her body has changed. Hence the headlines about "Ozempic babies." (See GLP-1s and PCOS.)

For women who want to conceive, this is, with care, good news: these drugs can be part of restoring the fertility that weight and PCOS had suppressed. For women who do not, it is a warning that needs to be said out loud.

The contraception catch

Here is the part that is too often left out of the appointment.

GLP-1 drugs slow how fast the stomach empties. That is part of how they work, it is why you feel full longer. But it also means that pills you swallow can be absorbed more slowly or less completely, including the oral contraceptive pill. The concern is greatest in the weeks right after starting, and after each dose increase, when stomach emptying changes the most. Tirzepatide's label specifically warns about this and advises a backup method.

Put the two facts together and you get a genuine risk: a woman's fertility is quietly returning at the same time as her pill may be working less reliably. That is the combination behind a lot of the surprise pregnancies.

What to actually do

This is very manageable once you know it. The practical steps:

• If you might want to conceive: these drugs are not approved in pregnancy and animal data raise concerns, so guidance is to stop a GLP-1 at least two months before trying. Plan it with your prescriber, do not just stop.
• If you do not want to be pregnant: talk to your doctor about a method the drug cannot undermine, a non-oral option such as an IUD, implant, injection or patch, or use a barrier method as backup, especially for the first four weeks and after each dose increase. (See GLP-1s and birth control.)
• If you become pregnant on a GLP-1: contact your doctor promptly. It is not a cause for panic, but the medication is normally stopped.

Why this matters more than it sounds

This is one of those gaps where the science is clear but the conversation often does not happen. A woman is handed a weight-loss drug and told about nausea, but not that it might both restore her fertility and weaken her pill. The result is avoidable surprises, in both directions: women who could conceive and are not told it is possible, and women who did not plan to and were not warned.

Knowing the mechanism puts you back in control of a decision that is entirely yours to make.

What it means for you

Have the conversation before you need to. If pregnancy is a goal, you now know these drugs may help, and that they must be stopped first. If it is not, you now know not to rely on the pill alone in the early weeks. Either way, this is a five-minute discussion with your prescriber that prevents a life-changing surprise.

What Steady does with this

This is exactly the kind of thing a cycle-aware tool exists to surface, because it lives at the intersection of your medication and your cycle, where most apps go silent.

• Steady tracks your cycle and period alongside your dose, so a return of regular cycles, often the first sign fertility is coming back, is something you can actually see.
• It keeps a clear record of your dose changes, the windows when contraception absorption is most affected.
• It puts your cycle and medication in one place, so the conversation with your prescriber starts from your real pattern, not a vague memory.

The drug can quietly change your fertility. Steady helps make sure nothing about that is a surprise.

Read next: GLP-1s and birth control, GLP-1s and PCOS, and GLP-1s and pregnancy.

Sources

1. Eli Lilly. Mounjaro (tirzepatide) Prescribing Information: oral contraceptive interaction. FDA label
2. Legro RS, et al. Weight loss and ovulation in women with PCOS. J Clin Endocrinol Metab (review). PubMed
3. Jastreboff AM, et al. Tirzepatide Once Weekly for Obesity (SURMOUNT-1). NEJM 2022;387:205-216. NEJM
4. American College of Obstetricians and Gynecologists. Obesity and reproduction. ACOG

Medical disclaimer: Articles in the Steady research hub are educational, not medical advice. Decisions about pregnancy, contraception and stopping medication belong with your doctor. See our full medical disclaimer.